Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation

E Marschan1, M Kuitunen, K Kukkonen

  • 1The Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. emma.marschan@hus.fi

Insights

Probiotic use in allergy-prone infants increased markers of low-grade inflammation, including C-reactive protein (CRP). Higher CRP levels at 6 months were linked to a reduced risk of eczema and allergic disease by age 2.

Area of Science:

  • Immunology
  • Microbiology
  • Allergy Research

Background:

  • Probiotics are investigated for allergic disease prevention, but their mechanisms remain unclear.
  • Understanding probiotic effects on infant immune responses is crucial for allergy management.

Purpose of the Study:

  • To investigate the impact of probiotic supplementation on in vivo immune responses in allergy-prone infants.
  • To analyze cytokine, antibody, and inflammatory markers in relation to probiotic use and allergic outcomes.

Main Methods:

  • A randomized, double-blind study involving mothers and infants with allergy risk factors.
  • Plasma analysis for C-reactive protein (CRP), immunoglobulins (IgA, IgE, IgG), and cytokines (IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma).
  • Correlation of immunological parameters at 6 months with probiotic treatment and allergic phenotype at 2 years.

Main Results:

  • Infants receiving probiotics showed elevated CRP, total IgA, total IgE, and IL-10 compared to placebo.
  • Increased CRP at 6 months was associated with significantly lower odds of developing eczema and allergic disease by age 2.
  • Probiotic-induced inflammation markers (CRP, IgE, IgA, IL-10) were identified.

Conclusions:

  • Chronic, low-grade inflammation, as indicated by CRP, may protect against eczema development in children.
  • Probiotic-induced immune modulation, characterized by elevated IgE, IgA, and IL-10, resembles mechanisms seen in helminth infections.
  • Chronic microbial exposure plays a role in immune modulation and allergy prevention.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...